Article
Gene editing is suitable to treat GM1 Gangliosidosis: a proof-of-concept study
2022-04-17
Abstract excerpt
Ganglioside-monosialic acid (GM1) gangliosidosis, a rare autosomal recessive disorder, is frequently caused by deleterious single nucleotide variants (SNVs) in GLB1 gene. These variants result in reduced β-galactosidase (β-gal) activity, leading to neurodegeneration associated with premature death. Currently, no effective therapy for GM1 gangliosidosis is available. Three ongoing clinical trials aim to deliver a...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 716e38a4-e676-50bc-a4bb-979a8e74808b
- DOI
- 10.1101/2022.04.17.488473
